Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지

Cause-specific Analysis of Risk Factors in Completely Resected Pathologic Stage Ia Non-small Cell Lung Cancer

병리학적 병기 Ia기 비소세포폐암 환자에서 완전절제술 후 사망의 원인에 따른 위험인자 분석

  • Park, Seong-Yong (Department of Thoracic Cardiovascular Surgery, Center for Lung Cancer, Research Institute and Hospital) ;
  • Park, In-Kyu (Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine) ;
  • Byun, Chun-Sung (Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine) ;
  • Lee, Chang-Young (Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine) ;
  • Bae, Mi-Kyung (Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine) ;
  • Kim, Dae-Joon (Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine) ;
  • Chung, Kyung-Young (Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine)
  • 박성용 (국립암센터 폐암센터 흉부외과) ;
  • 박인규 (연세대학교 의과대학 흉부외과학교실) ;
  • 변천성 (연세대학교 의과대학 흉부외과학교실) ;
  • 이창영 (연세대학교 의과대학 흉부외과학교실) ;
  • 배미경 (연세대학교 의과대학 흉부외과학교실) ;
  • 김대준 (연세대학교 의과대학 흉부외과학교실) ;
  • 정경영 (연세대학교 의과대학 흉부외과학교실)
  • Published : 2009.12.05
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Lobectomy and more extended anatomic resection are regarded as standard treatment for stage Ia non-small cell lung cancer, but approximately 15~40% of patients suffer from treatment failures such as cancer recurrence or death. The authors analyzed types and causes of treatment failures in surgically treated cases of stage Ia non small cell lung cancer. Material and Method: We retrospectively reviewed the medical records of 156 patients who had undergone complete resection for stage Ia NSCLC between Jan 1992 and Aug 2005. Patients were divided into two different treatment failure groups: cancer-related deaths and non-cancer-related deaths. Risk factors were analyzed in each group by the Kaplan-Meyer survival method and the Cox proportional hazard model. Result: Among the 156 patients, 93 were males; the mean age was 61. The median follow-up period was 33.8 months. The 5 year survival rate was 87.6%. Microscopic lympho-vascular permeation was reported in 10 patients. Recurrence was reported in 19 patients and 12 patients died due to recurrent lung cancer. Noncancer related deaths occurred in 16 patients. Risk factors for cancer recurrence and cancer related death were microscopic lympho-vascular permeation (HR=6.81, p=0.007, HR=7.81, p<0.001); for non-cancer related death, risk factors were pneumonectomy (HR=25.92, p=0.001) and postoperative cardiopulmonary complications (HR=29.67, p=0.002). Conclusion: After complete resection of stage Ia non small cell lung cancer patients, mortality includes not only cancer related deaths but also cancer unrelated deaths. Adjuvant chemotherapy is advised for patients who show microscopic lympho-vascular permeation, which is a risk factor for recurrence and for cancer related death. Patients who had pneumonectomy or who suffered from cardiac or respiratory complications need meticulous care in order to reduce comorbidity-induced death.

배경: Ia 병기의 비소세포성폐암에서 폐엽 절제술과 종격동 림프절 청소술은 표준 치료로 받아들여지고 있으나 약 15~40%의 환자의 재발 또는 사망 등의 치료 실패를 경험하게 된다. 저자들은 Ia 비소포성폐암에서의 치료 실패 유형을 분석하고 각각에 따른 위험 인자를 분석하고자 하였다. 대상 및 방법: 1992년 1월부터 2005년 8월까지 비소세포성폐암으로 완전(R0)절제술을 시행받은 156명의 환자를 대상으로 후향적인 연구를 시행하였다. 치료 실패의 원인을 폐암연관 사망 및 폐암무관 사망으로 분류하고 각각의 위험인자를 분석하였다. 결과: 전체 156명의 환자중 남자가 93명, 여자는 63명이었으며, 평균 연령은 61.31세였다. 중앙 추적관찰 기간은 33.8개월이었다. 5년 생존율은 87.6%였고 10년 생존율은 78.3%였다. 미세 림프관-혈관 침윤이 있었던 환자는 10명이었다. 추적기간 중 19예의 폐암재발이 진단되었으며, 12예의 폐암연관 사망이 발생하였다. 폐암무관 사망은 16예에서 발생하였다. 폐암 재발과 폐암연관 사망의 위험인자는 미세 림프관-혈관 침윤(HR=6.81, p=0.007, HR=7.81, p<0.001)이었으며, 폐암무관 위험인자는 전폐절제술(HR=25.92, p=0.001)과 수술 후 심혈관계 또는 호흡기계통의 합병증 발생여부(HR=29.67, p=0.002)인 것으로 나타났다. 결론: Ia 비소세포성폐암의 완전절제술 후 사망 원인은 재발과 이로 인한 폐암연관 사망뿐만 아니라 폐암무관 사망 또한 많은 비율을 차지한다. 재발 및 폐암연관 사망의 위험인자인 미세 림프관-혈관 침윤이 있는 환자들 대상으로 수술 후 보조 항암요법을 선택적으로 시행하는 것이 도움이 될 수 있을 것으로 판단되며, 전폐절제술을 받은 환자나 심혈관계 또는 호흡기계 합병증이 발생했던 환자들에 있어서는 병발증으로 인한 사망을 줄이기 위해 세심한 관리가 필요할 것으로 판단된다.

Keywords

References

  1. Goodgame B, Viswanathan A, Miller C, et al. A clinical model to estimate recurrence risk in resected stage i non-small cell lung cancer. Am J Clin Oncol 2008;31:22 https://doi.org/10.1097/COC.0b013e3180ca77d1
  2. Al-Kattan K, Sepsas E, Fountain S, Townsend E. Disease recurrence after resection for stage I lung cancer. Eur J Cardiothorac Surg 1997;12:380-4 https://doi.org/10.1016/S1010-7940(97)00198-X
  3. Ost D, Goldberg J, Rolnitzky L, Rom W. Survival after surgery in stage IA and IB non-small cell lung cancer. Am J Respir Crit Care Med 2008;177:516 https://doi.org/10.1164/rccm.200706-815OC
  4. Rena O, Oliaro A, Cavallo A, et al. Stage I non-small cell lung carcinoma: really an early stage? Eur J Cardiothorac Surg 2002;21:514-9 https://doi.org/10.1016/S1010-7940(01)01153-8
  5. Ou S, Zell J, Ziogas A, Anton-Culver H. Prognostic factors for survival of stage I nonsmall cell lung cancer patients: A population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003. Cancer 2007;110:1532-41 https://doi.org/10.1002/cncr.22938
  6. Chang M, Mentzer S, Colson Y, et al. Factors predicting poor survival after resection of stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg 2007;134:850-6 https://doi.org/10.1016/j.jtcvs.2007.03.044
  7. Bodendorf M, Haas V, Laberke H, Blumenstock G, Wex P, Graeter T. Prognostic value and therapeutic consequences of vascular invasion in non-small cell lung carcinoma. Lung Cancer 2009;64:71-8 https://doi.org/10.1016/j.lungcan.2008.07.011
  8. Miyoshi K, Moriyama S, Kunitomo T, Nawa S. Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2008;137:429-34 https://doi.org/10.1016/j.jtcvs.2008.07.007
  9. Goldstraw P, Crowley J, Chansky K, et al. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (Seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007;2:706 https://doi.org/10.1097/JTO.0b013e31812f3c1a
  10. Gajra A, Newman N, Gamble G, et al. Impact of tumor size on survival in stage Ia non-small cell lung cancer. Lung Cancer 2003;42:51-7 https://doi.org/10.1016/S0169-5002(03)00285-X
  11. Wang C, Lin Y, Tzao C, et al. Comparison of Charlson comorbidity index and Kaplan-Feinstein index in patients with stage I lung cancer after surgical resection. Eur J Cardiothorac Surg 2007;32:877-81 https://doi.org/10.1016/j.ejcts.2007.09.008
  12. Kim D, Lee J, Lee C, Park I, Chung K. Long-term survival following pneumonectomy for non-small cell lung cancer: clinical implications for follow-up care. Chest 2007
  13. Alexiou C, Beggs D, Onyeaka P, et al. Pneumonectomy for Stage I (T1N0 and T2N0) nonsmall cell lung cancer has potent, adverse impact on survival. Ann Thorac Surg 2003; 76:1023-8 https://doi.org/10.1016/S0003-4975(03)00883-X
  14. Kinugasa S, Tachibana M, Yoshimura H, et al. Postoperative pulmonary complications are associated with worse short- and long-term outcomes after extended esophagectomy. J Surg Oncol 2004;88:71-7 https://doi.org/10.1002/jso.20137